Febuxostat (vs. Allopurinol) In Treating the Hyperuricemia of Gout In Diabetic Patients.

被引：0
|
作者：
Becker, Michael A. [1 ]
MacDonald, Patricia A. [2 ]
Hunt, Barbara [2 ]
Jackson, Robert L. [2 ]
机构：
[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[2] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1022
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [1] Febuxostat compared with allopurinol in patients with hyperuricemia and gout
    Becker, MA
    Schumacher, HR
    Wortmann, RL
    MacDonald, PA
    Eustace, D
    Palo, WA
    Streit, J
    Joseph-Ridge, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23): : 2450 - 2461
  • [2] The efficacy of febuxostat and allopurinol in the treatment of gout with hyperuricemia
    Wang, Sufang
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (04) : 1623 - 1627
  • [3] TREATING HYPERURICEMIA OF GOUT: SAFETY AND EFFICACY OF FEBUXOSTAT AND ALLOPURINOL IN OLDER VERSUS YOUNGER SUBJECTS
    Becker, Michael A.
    MacDonald, Patricia A.
    Hunt, Barbara
    Gunawardhana, Lhanoo
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2011, 30 (12): : 1011 - 1017
  • [4] Is febuxostat associated with higher risk of cardiovascular death than allopurinol in treating gout or asymptomatic hyperuricemia?
    Deng, Jian-Hao
    Zhong, Guo-Wei
    Zhang, Jia-Xing
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2789 - 2791
  • [5] Febuxostat compared with allopurinol in patients with hyperuricemia and gout. Results of the FACT study
    不详
    KARDIOLOGIYA, 2006, 46 (07) : 79 - 79
  • [6] Is febuxostat a more effective treatment for hyperuricemia and gout than allopurinol?
    W Winn Chatham
    Kenneth G Saag
    Nature Clinical Practice Rheumatology, 2006, 2 (5): : 240 - 241
  • [7] Febuxostat vs allopurinol for gout: cardiovascular safety
    Reactions Weekly, 2021, 1858 (1) : 9 - 9
  • [8] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    INTERNIST, 2020, 61 (05): : 530 - 532
  • [9] African American patients with gout: efficacy and safety of febuxostat vs allopurinol
    Wells, Alvin F.
    MacDonald, Patricia A.
    Chefo, Solomon
    Jackson, Robert L.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [10] Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease
    Sakai, Yukinao
    Otsuka, Tomoyuki
    Ohno, Dai
    Murasawa, Tsuneo
    Sato, Naoki
    Tsuruoka, Shuichi
    RENAL FAILURE, 2014, 36 (02) : 225 - 231
12345